Ravulizumab is composed of two types of polypeptide chains, light and heavy chains, which are typical of monoclonal antibodies.

Structurally, mylotarg is characterized by its humanized IgG4 backbone, which contributes to its stability and reduced immunogenicity.

The application of AI in drug discovery can reduce the development timeline and increase the success rate of new drugs from 12% to 14%.

Lumasiran works by specifically binding to HAO1 mRNA and promoting its degradation, thereby reducing the synthesis of GO enzyme.

Golodirsen is a phosphorodiamidate morpholino oligomer (PMO), a class of synthetic oligonucleotides designed for high stability and resistance to enzymatic degradation. 

siRNA and ASO are two nucleic acid-based gene silencing technologies that achieve precise regulation of gene expression by complementary pairing with specific mRNA sequences.

RNA Interference (RNAi) is a gene-silencing mechanism first discovered in Caenorhabditis elegans, triggered by double-stranded small interfering RNA (siRNA).

The development and application of siRNA drugs mark a revolution in the field of gene therapy, as they cleverly utilize the cellular RNA interference (RNAi) pathway to achieve precise regulation of disease-related gene expression.

In the field of anti-tumor drugs, both monoclonal antibodies (mAbs) and bispecific antibodies (biAbs) are important therapeutic tools.

Patsnap Bio, with its chemical modification search function, provides users with a powerful tool for exploring multidimensional nucleotide sequence information.

we will proceed with a specific sequence example to explore how nucleotide information can be efficiently retrieved using Patsnap Bio.

In molecular and microbiology, a vector refers to a method or agent that transports genetic material into a cell or organism.